Home-based records (HBRs) are an important tool for recording and communicating within primary healthcare service delivery. Unfortunately, HBRs are currently unable to fulfil their intended purpose in many communities either because the HBR is not functionally well-designed to serve its objectives, not made available, not fully adopted and/or not appropriately utilized by caregivers and/or health workers. This brief report describes the occurrence of nationally reported HBR stock-outs and HBR financing patterns during 2014 and 2015 across 195 countries reporting immunization system performance data to the World Health Organization and United Nations Children's Fund. National level HBR stock-outs were reported by 19 and 22 countries during 2014 and 2015, respectively, with eleven countries reporting stock-outs during both 2014 and 2015. During 2015, 12 of the 22 countries reporting HBR stock-outs were from the African Region and two-thirds of the countries were Gavi-eligible. Information on HBR stock-outs was either not available or not reported by 66 countries (19 were Gavi-eligible) for 2014 and 53 (11 were Gavi-eligible) countries for 2015. Among the 22 countries reporting HBR stock-outs in 2015, 12 (54%) countries reported a single HBR financing source, and nine (41%) countries reported more than one source for HBR financing. The occurrence of HBR stock-outs remains a concern, particularly in Gavi-eligible countries introducing new vaccines where dedicated funding is received for revising and printing new recording tools, including HBRs. Additional attention is needed to understand the root causes for stock-outs and identify solutions to ensure a well-designed, durable HBR is readily available in the right quantity, in the right place at the right time in all countries.
Introduction
Home-based personal health records-from this point forward referred to as home-based records (HBRs)-used to record immunization and other primary care services received (including the date-of-service) by individuals are an important tool within primary healthcare service delivery that encourages a partnership in the care of the child between the healthcare worker and the caregiver.
Within primary healthcare service delivery, HBRs are an important recording tool and information resource (i) to enhance health professionals' ability to make appropriate clinical decisions (e.g., which vaccinations have been received already and which vaccinations remain outstanding) and improve continuity of care across providers in the absence of other health records, (ii) to empower individuals or their caregivers as a vehicle for health education about which primary healthcare services have been received and those which remain outstanding as well as (iii) to support public health monitoring efforts (i.e., through population-based vaccination coverage surveys). Unfortunately, HBRs are currently unable to fulfil their intended purpose in many communities either because the HBR is not functionally well-designed to serve the needs above, not made available, not fully adopted and/or not appropriately utilized by caregivers and/or health workers.
The challenges of HBR availability have previously been highlighted with nearly one-quarter of respondent countries reporting national level HBR stock-outs during 2013 [1] , meaning that the HBR was not printed in sufficient quantities for all newborns and their caregivers to receive a document that they are rightly due as part of national promises made in the Convention on the Rights of the Child (Articles 3 and 24) [2] to protect children's health through primary healthcare and engagement of caregivers in making decisions about the healthcare (and vaccination needs) of their child. This report describes an update on reported HBR stock-outs by countries during 2014 and 2015 (reported during 2015 and 2016, respectively). We also describe reported HBR financing patterns during the same period.
Methods

Data Source
Since 1998, the World Health Organization (WHO) and United Nations Children's Fund (UNICEF) have jointly collected national immunization system performance data using a standardized data collection form, the Joint Reporting Form on Immunization (JRF). Since its inception, the JRF, which was imple-mented to avoid the publication and dissemination of discrepant immunization system performance data and to take advantage of operational efficiencies within each agency, has evolved from a limited set of information collected using a paper-based form to one based in MS Excel (Microsoft Corporation, Redmond, Washington) capturing a wide range of domains of standard performance, planning, financing and quality indicators (Box 1). The information collected in the JRF serves as a critical resource for tracking implementation of the Global Vaccine Action Plan (GVAP), endorsed by all WHO Member States at the World Health Assembly (WHA) in 2012 [3] , and the Regional Vaccine Action Plans (RVAPs). These initiatives serve as key frameworks to guide immunization strategies at global and regional levels, and progress reports on GVAP, devel- Results were tallied at the global level and by WHO operational region (see www.who.int/about/structure) and eligibility for Phase 2 financial support from Gavi, the Vaccine Alliance (see www.gavi.org).
Questions on Home-Based Record Stock-Outs and Financing
Results
A total of 19 countries reported national level HBR stock-outs during 2014, and 22 countries reported HBR stock-outs during 2015 (Table 1) were from the African Region, five from the Western Pacific Region, three from the Region of the Americas and one each from the Eastern Mediterranean and South-East Asia Regions (Annex). Seven of the 11 countries reporting HBR stock-outs during 2014 and 2015 were from Africa, two from the Region of the Americas and one each from the Eastern Mediterranean and Western Pacific Regions. Among the countries reporting HBR stock-outs in 2014, nearly half were Gavi-eligible; in 2015, two-thirds of the countries reporting stock-outs were Gavi-eligible.
Information on HBR stock-outs was either not available or not reported by 66 countries (19 were Gavi-eligible) for 2014 and 53 (11 were Gavi-eligible) countries for 2015. We are aware of two countries, Belarus and Norway that notified the WHO in 2014 that they do not utilized HBRs in their immunization system. Of the 53 countries without a report on HBR stock-outs for 2015 (Norway and Belarus reported during 2013 that they do not use home-based records [1] ), five countries were from the African Region, five countries from the Region of the Americas, seven countries from the Eastern Mediterranean Region, 26 countries from the European Region, two countries from South-East Asia and eight countries from the Western Pacific Region.
Overall, 80 countries reported that EPI/MOH was solely responsible for HBR financing, five countries noted that another government agency was solely responsible and 11 countries noted that other non-governmental partners were solely responsible for HBR financing. Among the remaining 99 countries, 40 countries reported more than one source of HBR financing (59 countries either chose not to report information on HBR financing or had no data to report). 
Comment
Of the more than 140. Recent immunization programme reports highlight reductions in funding and delays in securing funding for vaccines and it is reasonable to presume recording tools are similarly impacted [5] . It is understandable that it will take time for county governments in Kenya to improve their capacity to manage such supply chain systems on their own or for alternate models to develop; however, further attention is needed to provide structure for the HBR supply chain management in order to resolve the two-year HBR stock-out problems.
The number of countries who either did not report or did not have data on whether there was a HBR stock-out is also concerning. Countries have been encouraged to include HBR availability among the programme performance indicators [6] . The absence of information on whether HBR stock-outs occur in a country may serve as a signal of more broad problems in a country's recording and reporting system, not unlike the situation with stock-outs of vaccines and injection supplies. It is important to monitor the quantity of HBRs available at the operational, district, provincial and national levels and to accurately forecast needs for home-based records to prevent stock-outs as well as unnecessary overstocks [1] . The importance of monitoring HBR availability and distribution is of particular importance in settings where more than one governmental department is involved in recording and reporting tool development/update processes as well as maintenance and management. As suggested above, inter-departmental communication and coordination failures have been previously cited though the frequency of the problem is unknown (and perhaps irrelevant).
It is important to note that the data reported here only reflect information regarding stock-outs at national level. HBR stock-outs at the district level may occur either in the presence or absence of stock-outs at national level. Unfortunately, the questions asked of countries for the 2014 and 2015 periods did not ask about HBR stock-outs at this level, which is an important limitation as highlighted by others [7] with regards to other commodities. Stock-outs may also occur in the private sector and are not included. The reported data also do not provide any indication of the duration of the HBR stock-out. Prior results ob-served national HBR stock-out durations on average of seven months at the national level and of six months at district level [1] . Also, our ability to tease out countries that chose not to report from those who did not have data on HBR stock-outs is limited here. Beginning with the 2017 data collection cycle for 2016 immunization system performance data, this issue will be addressed directly.
Our understanding of the root causes behind HBR stock-outs is currently lagging behind but it is necessary in order to develop sustainable solutions for both the near and long-term. Prior work [1] hypothesized complex HBR financing and coordination/management settings, such as when the responsibility of HBR procurement is a shared responsibility of the national immunization programme and another department (e.g., nutrition) and heavy dependence on external funding with rapid withdrawal of funding in the absence of dedicated budget lines in costed multi-year plans for HBRs as potential contributing factors. In other instances, simple neglect of the records as a priority against a backdrop of suboptimal tracking systems for durable commodities may explain much of the problem. Further operational research is needed to understand the viability and potential (dis-)advantages of bundling HBRs with other vaccination delivery commodities as mechanism to reduce the risk of such stock-outs. But, this is only one possible solution of many that might be explored. 
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